These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5048653)

  • 1. Impairment of cognitive function associated with hydroxyamylobarbitone accumulation in patients with renal insufficiency.
    Balasubramaniam K; Mawer GE; Pohl JE; Simons PJ
    Br J Pharmacol; 1972 Jun; 45(2):360-7. PubMed ID: 5048653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of amylobarbitone in patients with chronic liver disease.
    Mawer GE; Miller NE; Turnberg LA
    Br J Pharmacol; 1972 Mar; 44(3):549-60. PubMed ID: 5040665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of amylobarbitone metabolism in healthy men and women.
    Balasubramaniam K; Lucas SB; Mawer GE; Simons PJ
    Br J Pharmacol; 1970 Jul; 39(3):564-72. PubMed ID: 5472203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The excretion of hydroxyamylobarbitone in man after oral administration of amylobarbitone and hydroxyamylobarbitone.
    Grove J; Toseland PA
    J Pharm Pharmacol; 1971 Dec; 23(12):936-40. PubMed ID: 4402019
    [No Abstract]   [Full Text] [Related]  

  • 5. The prognostic value of the hydroxyamylobarbitone amylobarbitone ratio.
    Grove J; Toseland PA
    Arh Hig Rada Toksikol; 1970; 21(4):353-62. PubMed ID: 5525122
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of paracetamol on amylobarbitone hydroxylation in man: a gas chromatographic method for simultaneous estimation of underivatized paracetamol and barbiturates.
    Kinsella HC; Smith S; Rogers HJ; Toseland PA
    J Pharm Pharmacol; 1979 Mar; 31(3):153-6. PubMed ID: 34688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estimation of amylobarbitone and hydroxyamylobarbitone in serum by gas liquid chromatography.
    Balasubramaniam K; Mawer GE; Rodgers EM
    Br J Pharmacol; 1969 Oct; 37(2):546P-547P. PubMed ID: 5348459
    [No Abstract]   [Full Text] [Related]  

  • 8. N-Hydroxyamylobarbitone--a metabolite of amylobarbitone?
    Gilbert JN; Nelmes PT; Powell JW; Murray S
    J Pharm Pharmacol; 1978 Sep; 30(9):595. PubMed ID: 29107
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of age on the hydroxylation of amylobarbitone sodium in man.
    Irvine RE; Grove J; Toseland PA; Trounce JR
    Br J Clin Pharmacol; 1974 Feb; 1(1):41-3. PubMed ID: 22454867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gas-liquid chromatography of hydroxyamylobarbitone in plasma and urine.
    Grove J; Toseland PA
    Clin Chim Acta; 1970 Aug; 29(2):253-60. PubMed ID: 5493182
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma concentrations of diazepam, noradiazepam and amylobarbitone after short-term treatment of anxious patients.
    Tansella M; Zimmermann Tansella C; Ferrario L; Preziati L; Tognoni G; Lader M
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):68-75. PubMed ID: 347466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of low doses of amylobarbitone sodium and diazepam on human performance.
    Hart J; Hill HM; Bye CE; Wilkinson RT; Peck AW
    Br J Clin Pharmacol; 1976 Apr; 3(2):289-98. PubMed ID: 973963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of barbiturates and their metabolites in small plasma samples by gas chromatography-mass spectrometry. Amylorbarbitone and 3'-hydroxyamylobarbitone.
    Draffan GH; Clare RA; Williams FM
    J Chromatogr; 1973 Jan; 75(1):45-53. PubMed ID: 4734364
    [No Abstract]   [Full Text] [Related]  

  • 14. The distribution of amylobarbitone, butobarbitone, pentobarbitone and quinalbarbitone and the hydroxylated metabolites in man.
    Robinson AE; McDowall RD
    J Pharm Pharmacol; 1979 Jun; 31(6):357-65. PubMed ID: 39132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium amylobarbitone in the differential diagnosis of confusion.
    Ward NG; Rowlett DB; Burke P
    Am J Psychiatry; 1978 Jan; 135(1):75-8. PubMed ID: 618531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the clearance of amylobarbitone from a single plasma measurement.
    Bachmann K
    Br J Clin Pharmacol; 1987 Jan; 23(1):94-8. PubMed ID: 3814466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pH on aggregation and protein binding of barbituric acid and amylobarbitone.
    Mikikits W; Skinner A; Spector RG; Watts DC
    Br J Pharmacol; 1971 Jan; 41(1):76-83. PubMed ID: 5547763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A repeated dose comparison of dichloralphenazone, flunitrazepam and amylobarbitone sodium on some aspects of sleep and early morning behaviour in normal subjects.
    Hindmarch I; Parrott AC; Arenillas L
    Br J Clin Pharmacol; 1977 Apr; 4(2):229-33. PubMed ID: 16635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-dose study on the human metabolism of amylobarbitone.
    Baldeo WC; Gilbert JN; Powell JW
    Xenobiotica; 1979 Apr; 9(4):205-8. PubMed ID: 483856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of reduced red blood cell deformability and diabetic nephropathy.
    Brown CD; Ghali HS; Zhao Z; Thomas LL; Friedman EA
    Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.